JEAN MICHEL BRUNEL | Microbiology | Research Excellence Award

Dr. Jean Michel Brunel | Microbiology | Research Excellence Award

CRHC | Faculty of Pharmacy | France

Dr. Jean Michel Brunel is a distinguished French chemist whose research focuses on organic synthesis, medicinal chemistry, and antimicrobial drug discovery. As a senior CNRS Researcher and group leader at Aix-Marseille Université, he leads a team developing antibiotic adjuvants, polyamine derivatives, and next-generation antimicrobial agents. His work integrates medicinal chemistry, microbiology, and organoselective synthesis to create therapeutic probes and drug prototypes that target bacterial pathways, disrupt biofilms, and enhance antibiotic efficacy against multi-drug-resistant bacteria, including Pseudomonas aeruginosa. Brunel’s research spans natural product chemistry, synthetic scaffolds, and bile acid analogues, extending from in vitro screening to in vivo models to ensure translational impact. Supported by major research grants, international collaborations, and industrial partnerships, his efforts advance the development of innovative anti-infective therapies. His prolific output includes 235 publications cited over 7,700 times across more than 6,200 documents, with an h-index of 42, reflecting his significant influence on global antimicrobial research and drug discovery.

Profiles: Scopus | ORCID | Google Scholar

Featured Publications

Permeabilize, but choose wisely: Selective antibiotic potentiation through outer membrane disruption in Pseudomonas aeruginosa. International Journal of Molecular Sciences.

Adaptation to cinnamaldehyde shapes Pseudomonas aeruginosa resistance to major antibiotics. Journal of Bacteriology.

Accurate antibiotic accumulation in Enterobacteriaceae isolates expressing efflux pumps. Biochimica et Biophysica Acta Biomembranes.

Don’t miss out on new publications by this author!

Bioinspired syntheses of the marine pyridoacridine alkaloids 2-Bromo and 3-Bromodeoxyamphimedine and structure correction of 2-Bromoamphimedine. Journal of Natural Products.

Efflux-mediated resistance in Enterobacteriaceae: Recent advances and ongoing challenges to inhibit bacterial efflux pumps.

Uric acid, the end-product of purine metabolism, mitigates tau-related abnormalities: Comparison with DOT, a non-antibiotic oxytetracycline derivative. Biomolecules.

 

Getachew Alamnie | Microbiology | Editorial Board Member

Assist Prof Dr. Getachew Alamnie | Microbiology | Editorial Board Member 

Researcher | Mekdela Amba University | Ethiopia

Dr. Getachew Alamnie is an Ethiopian researcher whose work spans molecular biology, biotechnology, nanotechnology, and microbial bioprocessing. His contributions include important findings on the association between Vitamin D deficiency, VDR FokI gene polymorphisms, and diabetic retinopathy complications in Ethiopian patients with type 2 diabetes. In biotechnology, he has advanced microbial enzyme applications through the production of keratinase from Bacillus subtilis GH2 for sustainable feather biodegradation. Dr. Alamnie also contributes extensively to nanoscience, co-authoring impactful studies on the antibacterial properties of metallic nanoparticles and green-synthesized silver nanoparticles designed to combat multidrug-resistant bacteria. His research further extends to agricultural biotechnology, especially the use of CRISPR/Cas9-mediated genome editing to enhance crop resilience against abiotic stress. He has additionally explored innovative bioprocessing strategies, including the use of chicken feather protein hydrolysate as an affordable peptone source for microbial cultivation. With 17 citations across 14 documents, 7 published papers, and an h-index of 3, Dr. Alamnie’s growing scholarly influence reflects his strong multidisciplinary contributions to health, agriculture, and environmental sustainability.

Profiles: Scopus | ORCID

Featured Publications

Melake, A., Alamnie, G., & Mekonnen, M. Association of vitamin D deficiency and vitamin D receptor FokI gene polymorphism with diabetic retinopathy complications in Ethiopian patients with type 2 diabetes mellitus. International Journal of Immunogenetics.

Girma, A., Mebratie, G., Mekuye, B., Abera, B., Bekele, T., & Alamnie, G. Antibacterial capabilities of metallic nanoparticles and influencing factors. Nano Select.

Adane, M., & Alamnie, G. CRISPR/Cas9 mediated genome editing for crop improvement against abiotic stresses: Current trends and prospects. Functional & Integrative Genomics.

Alamnie, G. Production of keratinase enzyme from B. subtilis GH2 and its application in feather biodegradation. Biomass Conversion and Biorefinery.

Pramod Bhasme | Microbiology | Best Review Paper Award

Dr. Pramod Bhasme | Microbiology | Best Review Paper Award 

McGowan Institute for Regenerative Medicine | India

Dr. Pramod Bhasme is a distinguished researcher specializing in microbiology, molecular biology, and regenerative medicine, with expertise in bacterial pathogenesis, biofilm regulation, and wound healing. He earned his B.Sc., M.Sc., and M.Phil. in Microbiology from Karnatak University Dharwad, India, where he studied bacteriocins and mastitis-related pathogens, before completing a Ph.D. in Microbiology at the University of Chinese Academy of Sciences, Beijing, under Prof. Ma Luyan. His doctoral research focused on quorum sensing, virulence regulation, and biofilm disruption in Pseudomonas aeruginosa. He later held a postdoctoral fellowship at Indiana University and currently serves as a Postdoctoral Associate at the McGowan Institute for Regenerative Medicine, University of Pittsburgh. His work explores electroceutical technologies, bacteriophage therapy, senescence biology, and wound-healing strategies using transgenic models. Dr. Bhasme’s research interests include quorum sensing inhibition, cyclic-di-GMP signaling, protein engineering, and macrophage–keratinocyte interactions, with a strong focus on translational medicine. A recipient of the CAS-TWAS President’s Fellowship, he has published in leading journals such as Nature Communications, ACS Nano, Environmental Microbiology, JoVE, and mLife. With 11 publications, 231 citations across 211 documents, and an h-index of 8, he is recognized as an emerging leader in infection biology and regenerative medicine.

Profile: Scopus | Google Scholar

Featured Publications

Sharma, A., Anthony, A. J., Gnyawali, S., Bhasme, P., et al. The mitochondrial bioenergetics of functional wound closure is dependent on macrophage to keratinocyte exosomal crosstalk. ACS Nano. (Accepted).

Zhang, Y., Bhasme, P., et al. Dual functions: A coumarin-chalcone conjugate inhibits cyclic-di-GMP and quorum sensing signaling. mLife, 2(3), 284–293.

El Masry, M., Bhasme, P., et al. Swine model of biofilm infection and invisible wound. Journal of Visualized Experiments, (196).

Pal, D., Ghatak, S., Bhasme, P., et al. Identification of a physiologic vasculogenic fibroblast state to achieve tissue repair. Nature Communications, 14(1), 1129.

Xu, A., Wang, D., Bhasme, P., et al. Mutations in WspA lock the Wsp signal system into an active state. Environmental Microbiology.

 

Mansour Sedighi | Microbiology | Best Researcher Award

Assist. Prof. Dr. Mansour Sedighi | Microbiology | Best Researcher Award

Author, at Kurdistan University of Medical Sciences, Iran.

Dr. Mansour Sedighi is a distinguished microbiologist specializing in medical bacteriology. With a Ph.D. from Iran University of Medical Sciences, his research focuses on antimicrobial resistance, foodborne pathogens, and molecular diagnostics. He possesses extensive experience in diagnostic microbiology, bacterial DNA sequencing, and immunoassay development. Dr. Sedighi has contributed significantly to understanding drug-resistant bacteria, with numerous publications in reputed journals. His expertise spans advanced molecular techniques, including PCR, qPCR, and various chromatographic methods. Passionate about microbial research, he continues to make significant strides in infectious disease control and bacterial genomics.

Professional Profile

Scopus

ORCID

Google Scholar

Education 🎓

Dr. Sedighi completed his Ph.D. in Medical Bacteriology from Iran University of Medical Sciences in 2017. Prior to that, he earned his M.Sc. in Medical Microbiology from Isfahan University of Medical Sciences in 2014. His academic journey began with a B.Sc. in Veterinary Laboratory Sciences from the University of Hamadan in 2011, followed by an Associate degree in Veterinary from the University of Zabol in 2009. His diverse educational background has provided him with a strong foundation in microbiology, molecular biology, and infectious disease research.

Experience 👨‍🎓

Dr. Sedighi has extensive experience in diagnostic and clinical microbiology, with expertise in antimicrobial resistance and bacterial genomics. He has worked with various molecular biology techniques, including PCR, qPCR, sequencing, and electrophoresis. His technical proficiency also includes protein purification, enterotoxin production, and chromatographic techniques like HPLC and FPLC. Dr. Sedighi has played a crucial role in developing immunoassays such as ELISA and RIA. His research has significantly contributed to understanding and combating bacterial resistance in clinical settings, making him a respected expert in the field.

Research Interest 🔬

Dr. Sedighi’s research focuses on antimicrobial resistance mechanisms, foodborne pathogens, and molecular diagnostics. He is particularly interested in developing rapid diagnostic techniques for drug-resistant bacteria and investigating new antimicrobial strategies. His work on metallo-β-lactamases in Pseudomonas aeruginosa has been instrumental in understanding resistance patterns in clinical isolates. Additionally, he explores nutritional studies and defined media development for bacterial growth and toxin production. His research aims to improve public health by addressing global microbial threats.

Awards 🏆

Dr. Sedighi has received numerous accolades for his contributions to microbiology and infectious disease research. His work on antimicrobial resistance has been recognized in both national and international scientific communities. His dedication to bacterial genomics and innovative diagnostic methods has earned him research grants and awards from esteemed medical and scientific organizations. He continues to push the boundaries of microbiological research with his groundbreaking studies.

Top Noted Publications 📚

Dr. Sedighi has authored numerous research papers in high-impact journals. His work spans antimicrobial resistance, bacterial genomics, and molecular diagnostics. Here are some notable publications:

  • Identification of Metallo-β-Lactamase and Drug Resistance Pattern of Pseudomonas aeruginosa Strains

    • Journal: Global Journal of Medicine Researches and Studies

    • Year: 2014

    • Citations: Cited by multiple studies

    • Focus: Investigates the presence of metallo-β-lactamases in Pseudomonas aeruginosa and their antimicrobial resistance patterns.

  • Antimicrobial Resistant Pattern of Pseudomonas aeruginosa Strains

    • Journal: Global Journal of Medicine Researches and Studies

    • Year: 2014

    • Citations: Widely referenced

    • Focus: Examines resistance patterns of Pseudomonas aeruginosa against different antimicrobial agents.

  • Identification of Non-Tuberculosis Mycobacteria by PCR-Restriction Enzyme Analysis

    • Journal: Journal of Isfahan Medical School

    • Year: 2014

    • Focus: Uses PCR-Restriction Enzyme Analysis for detecting non-tuberculous mycobacteria.

  • Prevalence and Antibacterial Resistance of Coagulase Negative Staphylococci

    • Journal: Journal of Isfahan Medical School

    • Year: 2014

    • Focus: Studies the occurrence and resistance patterns of coagulase-negative Staphylococci.

  • Molecular Detection of blaSPM-1 Gene in Pseudomonas aeruginosa

    • Journal: Biological Journal of Microorganism

    • Year: 2015

    • Focus: Identifies the blaSPM-1 resistance gene in Pseudomonas aeruginosa strains.

  • Serological Diagnosis of Helicobacter pylori Infection

    • Journal: Archives of Clinical Infectious Diseases (Arch Clin Infect Dis)

    • Year: 2015

    • Focus: Investigates serological methods for diagnosing Helicobacter pylori infection.

Conclusion

Dr. Mansour Sedighi is a highly qualified researcher in medical bacteriology with extensive publications and technical expertise. His work on antimicrobial resistance and clinical microbiology makes a significant contribution to the field. While he is a strong candidate for the Best Researcher Award, further international collaborations, research diversification, and leadership roles could further solidify his candidacy for top-tier recognition.

Nadia Jaidane | Microbiology | Women Researcher Award

Dr. Nadia Jaidane | Microbiology | Women Researcher Award

Postdoctoral researcher, at Faculty of medecine Sousse, Tunisia.

🌟 Dr. Nadia Jaidane is a distinguished microbiologist specializing in pharmaceutical sciences. Born on September 17, 1976, in Tunisia, she has made significant contributions to the field of clinical microbiology and bacterial resistance research. With over two decades of experience, she is currently a Professor of Paramedical Education at the Higher School of Health Sciences and Techniques of Monastir. Her research focuses on antimicrobial resistance, hospital hygiene, and infectious diseases, contributing to numerous scientific publications and international collaborations. She actively participates in scientific congresses and professional organizations, reinforcing her expertise in the field.

Professional Profile

Scopus

ORCID

Education

🎓 Dr. Jaidane holds a Ph.D. in Pharmaceutical Sciences, specializing in Microbiology, awarded with “Very Honourable Distinction” from the Faculty of Pharmacy of Monastir, Tunisia, in collaboration with the University of Paris-Sud. She also holds multiple master’s degrees in hospital hygiene, food quality and bioprocesses, and life and earth sciences, all obtained with honors. Additionally, she has a Graduate Diploma in Medical Biology and a Complementary Diploma in Medical Pedagogy from Faculty of Medicine Ibn El Jazzar – Sousse. Her diverse academic background equips her with expertise in microbiology, medical education, and quality management in healthcare.

Experience

💼 Dr. Jaidane has held several key roles in academia and healthcare. Since 2013, she has been a Professor of Paramedical Education, training students in medical biology. Previously, she served as a Hygienist Technician at the Department of Prevention and Security of Care at Sahloul University Hospital, where she contributed to infection control and hospital hygiene. She also worked as an Epidemiologist Technician and a Sleep/Neurodiagnostic Technician, demonstrating her versatility in medical sciences. Her extensive experience bridges research, clinical practice, and education in microbiology and public health.

Research Interests

📚 Dr. Jaidane’s research interests focus on antimicrobial resistance, infectious diseases, and hospital hygiene. She has conducted genomic studies on resistant bacterial strains, particularly Klebsiella pneumoniae and Acinetobacter baumannii, contributing to the understanding of bacterial resistance mechanisms. Her work also explores epidemiological trends in nosocomial infections and antibiotic consumption patterns in healthcare settings. Through her research, she aims to develop strategies for controlling and preventing bacterial infections in hospitals, thereby improving patient safety and public health outcomes.

Awards & Recognitions

🏆 Dr. Jaidane has received multiple honors throughout her career. She earned “Very Honourable Distinction” for her Ph.D. and “Honors” in all her master’s degrees. She has been an active member of scientific congresses, contributing to the advancement of microbiology and hospital hygiene. Additionally, she has played a pivotal role in several epidemiological studies on infection control, receiving recognition for her contributions to healthcare safety and antimicrobial resistance research.

Top Noted Publications

📚 Dr. Jaidane has authored multiple peer-reviewed publications in high-impact journals, including:

  • Genomic analysis of in vivo acquired resistance to colistin and rifampin in Acinetobacter baumannii

    • Journal: International Journal of Antimicrobial Agents, 2018

    • Citations: 50+

    • Summary: This study investigates genetic mechanisms underlying colistin and rifampin resistance in A. baumannii through whole-genome sequencing. It identifies mutations contributing to resistance development during treatment.

  • Genomic Insights into Colistin-Resistant Klebsiella pneumoniae

    • Journal: Antimicrobial Agents and Chemotherapy, 2018

    • Citations: 40+

    • Summary: This paper explores genetic adaptations in K. pneumoniae strains resistant to colistin, revealing mutations in genes associated with lipid A modification and efflux pumps.

  • Whole genome sequencing of NDM-1-producing ST85 Acinetobacter baumannii

    • Journal: International Journal of Antimicrobial Agents, 2018

    • Citations: 35+

    • Summary: The study characterizes A. baumannii ST85 strains harboring the NDM-1 carbapenemase gene, highlighting their genomic features and resistance determinants.

  • Temporal Variation in Antibiotic Resistance of Acinetobacter baumannii

    • Journal: The Open Microbiology Journal, 2019

    • Citations: 20+

    • Summary: This research analyzes the changing patterns of antibiotic resistance in A. baumannii over time, providing insights into epidemiological trends and resistance evolution.

  • Epidemiology of resistance and phenotypic characterization of carbapenem resistance

    • Journal: African Health Sciences, 2019

    • Citations: 15+

    • Summary: The study describes the epidemiology and resistance mechanisms of carbapenem-resistant bacteria, emphasizing phenotypic and molecular characterization.

  • Ten golden rules for optimal antibiotic use in hospital settings

    • Journal: World Journal of Emergency Surgery, 2023

    • Citations: 10+

    • Summary: This paper outlines key principles for antimicrobial stewardship in hospitals, aiming to reduce resistance development and improve patient outcomes.

Conclusion

Dr. Nadia Jaidane is a highly qualified candidate with a strong research portfolio in microbiology and antimicrobial resistance. Her extensive academic background, impactful publications, and active engagement in the scientific community make her a strong contender. To maximize her chances, demonstrating leadership in grant-funded projects, winning more international awards, and emphasizing research impact on public health policy would further strengthen her application.